MONDAY June 24, 2013 — The antibiotic Vibativ (telavancin) has been approved by the U.S. Food and Drug Administration to treat pneumonia caused by Staphylococcus aureus bacteria when other treatments aren’t suitable. Pneumonia, a lung infection, can be caused by different bacteria…
Source:Vibativ Approved for Certain Bacterial Pneumonia
Tuesday, June 25, 2013
Vibativ Approved for Certain Bacterial Pneumonia
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment